chrisvoncsefalvay/vaers-outcomes huggingface dataset:
medicine taste in her mouth; weakness; This is a spontaneous report from a contactable nurse (patient herself). A 56-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EL9266, Expiration date: Unknown) via an unspecified route of administration, administered in Deltoid Right on 05Mar2021 at 10:00 (56-year-old at vaccination) as Dose 2, Single for Covid-19 immunization. The patient's medical history included Epilepsy from 35 years-old of her age, RSD (reflex sympathetic dystrophy) since having surgery in 2009 and can't take injections in her left arm, Addison's disease from 2019, Hashimoto's disease from 2019. The patient had a lot of medications and would prefer not to provide over the phone. The patient had no adverse event prior to vaccination. The patient had not received any other vaccine 4 weeks prior to covid vaccination. The patient stated that all her family had a vaccination and had no problems. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EN5318) via an unspecified route, administered in Deltoid Right on 12Feb2021 at 10:00 (56-year-old at vaccination) as Dose 1, Single for Covid-19 immunization. After receiving the first dose she had no symptoms but after the second dose she did had a medicine taste in her mouth and then had weakness for about three weeks because of her Addison's, but did not have any pain, no fever no chills, just weakness. She could tell her body was fighting. Relevant test was reported as none. No investigation assessment was reported. She stated that she visited emergency room but was not under any treatment. The outcome of the events medicine taste in her mouth, weakness was recovered on an unknown date in 2021.  Follow-up attempts are completed. No further information is expected.
Upon awaking from extreme fatigue (minimally  abnormal for my current activity, day of the week & health status (menstrarion)) bowel movement felt as if barbed wire was being pulled throughout my whole lower GI tract until bowel movement was completed. I attributed to eating a large amount of candy covered cashews the night before until I saw a patient that received the Moderna 2nd dose the same day but different location with the same symptoms. However the patient said she had the pain for over 2 hours then subsided with bowel movement.   *I was extremely fatigue due to taking the 3rd series of the vaccine 1 month EARLY  (which I lied to get saying it was my first moderna because I am seeing my 84 yo grandmother that was out of her home state and hasn?t updated yet + my patients population is typically 65+ only, God forgive me ) at the end of a busy work week along with starting my me transition cycle, so I?m not sure if I had pain prior to the actual bowel movement for I was unable to do more than wake up and drink fluids prior and after the bm for total of 48hrs.
After receiving the vaccine while pt was standing she stated "she felt weird and her eyes looked weird. The she gagged a little and her face was pale so I called for help."  Nursing staff and this physician entered the room to find the patient sitting in a chair, pale, dusky fatigued, and clammy in appearance. This physician immediately ordered vitals be taken in every 10 to 15 minute intervals. Initially, pt's pulse was low at 57-60 and nursing staff was unable to obtain automated blood pressure.  SPo2 remained above 95% on room air during the entire encounter.  Manual blood pressure measurements were then ordered.  Cool compresses were applied and the patient was given fluids (water and soda). Glucose was taken. See scanned result and stable.  Duskiness in the face slowly resolved after 30 minutes. BPs remained stable after taking with a manual blood pressure cuff in the 110s systolic to 70s diastolic and stable x3. (110/70, 110/70 and final automated was 106/67).  Pulse continued to improve over the course of the 30 minutes of obtaining vitals with a final pulse of 76. Pt's color in the face returned to pink and normal from original dusky appearance. Pt was talking and behavior had resumed to baseline.  Per mom, patient has never had this occur with vaccines but has always been anxious with lab draws and IV placements.   After approximately 45 minutes of counseling, obtaining history, performing an exam , repeating vitals, patient was stable to go home . Emergency precautions given such as : change in behavior, pale , clammy skin, dusky appearance, fainting episode, difficulty breathing or any other worrisome sign or symptoms, Mom voiced understanding. Parent and patient instructed to ensure adequate hydration and nutrition status before any vaccines, lab draws or procedures to prevent recurrence in the future.
Pt was given 3 immunizations and was being instructed by MA to remain seated when pt had an episode of vasovagal syncope and fell off exam table and onto floor. She did strike her head. Pt was noted to be unresponsive for no more than several seconds by MA. Dr. was called into room immediately and found pt responsive at that time, breathing, with good color, and sitting on floor. Pt was lifted to table with assist of 3 staff and found to be diaphoretic and nauseated but did not vomit. Pt showed no focal neurologic signs. She did have mild erythema over the forehead, otherwise no head or facial swelling. On physical assessment, no other signs were noted and pt was following commands. Pt was observed for approx 10-15 minutes prior to being sent for head CT, which was negative for skull fx or internal head injury. Pt mother was advised by Dr. that pt sustained a concussion from the fall, and pt may c/o HA for a week or so. Pt mother advised to call if any change in pt condition or onset of new symptoms. Pt was observed in clinic setting for total of about 2 hours prior to leaving.
Employee gave vaccine to a patient from a punctured vial that was left in the fridge that had been punctured for >24 hours.
Generalized weakness and fatigue, joint pain for last month, and R arm immobility.
Around 1520, while in observation, client stated feeling dizzy and anxious. EMS attended and cleared client.
DIARRHEA, DEHYDRTAION, FLUSHING, WHEEZING, THROAT SWOLLEN.  USED BENADRYL 50GM AND XOPENEX INHALER 3 PUFFS EVERY 6 HOURS UNTIL RESOLVED IN 12 HOURS.
Vaccinator was using a syringe to administer vaccine. He reported that he tried to push down on the plunger but it was ?stuck? and would not inject. No fluid was expelled.  He also reported he tried to push down on the plunger over the sharps container after needle/syringe was removed from the patients arm, and it still would not push down. Vaccinator administered full dose using another syringe.
pt recv vax 14MAR96 & 25MAR96 pt devel a fever of 103.7 & a papular rash on trunk & back;pt recovered;
Starting at 1:00 a.m. and lasting for approximately 8-9 hours, I had a fever and was sweating; I could not sleep; my right arm was very painful; my entire body ached.  It felt like a very bad flu.  I took 800 mg of Advil, which helped, and felt well enough to go to work by noon.  I had COVID-19 approximately 90 days before my vaccination.  I have never had an adverse reaction to a vaccine in my life.
Patient indicates he got up very sick to his stomach and as day progressed felt weak. Oct 18 2015 felt better but weak and on Oct 19 2015 he was experiencing dizziness.
pt recv vax 21AUG96 & 22AUG96 pt was tested for EIV by ELISA & western blot;results were positive for ELISA & inconclusive for western blot;reporter was concerned about a false positive ELISA result for HIV;
Within 10 minutes of receiving the vaccine, I began feeling light headed and slightly nauseas.  I was sitting down in a chair and began to black out.  The next thing I remember is waking up on the floor next to the chair.  After drinking some water and eating some candy, I began to feel better.  After 40 minutes from receiving the shot, I was able to leave the facility on my own.
43 y/o female with localized reaction to anthrax vaccination, approximately 5 1/2 inch area of erythema (+) increase warmth. No other symptoms.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent conditions and medical history were reported. On 12-FEB-2016 the patient was inadvertently administered an expired dose of RECOMBIVAX HB (expired product administered) injection (lot # K009505, expiry date 07-FEB-2016) parenterally (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse effects were reported. The action taken with the therapy with RECOMBIVAX HB was unknown. The outcome of event was unknown. There was no product quality complaint reported. Additional information has been requested.
Almost 24 hours after vaccination- mild chills lasted 1 hour                                                                                Fever. Highest 101.1 lasted about 5 hours About 41 hours after vaccination- washed a load of towels like I always do. Some towels are blue and some are tan.                                                                               WHEN I REMOVED THE TOWELS FROM THE WASHING MACHINE THE TAN TOWELS WERE A VERY BRIGHT                                                                              LIME GREEN. ALMOST ILLUMINATED. AT FIRST I THOUGHT SOMETHING WAS WRONG WITH THE WASHING                                                                               MACHINE. PUT TOWELS IN THE DRYER. WHEN DRY THE TAN TOWELS WERE BACK TO TAN. THE NEXT DAY I                                                                               WASHED THE SAME TOWELS. STAYED TAN. STRANGEST THING EVER. ONLY THING I COULD COME UP WITH                                                                               FOR THE CAUSE WAS THE VACCINE.  I HAVE NOT HAD ANY OTHER EVENTS SINCE.
This spontaneous report was received from a registered nurse concerning a multiple unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unspecified dates, the patients were vaccinated with improperly stored doses of ZOSTAVAX subcutaneous injection (strength and dose were not reported) (lot # M032638, expiration date 04-OCT-2017) for prophylaxis. According to the reporter, ZOSTAVAX doses were exposed to the following temperatures excursions: 2 hours and 12 minutes between more than 5 degrees Fahrenheit (F) but less than 14 F, for 48 minutes between more than 14 F but less than 46 F, and for 8 hours and 15 minutes between more than 5 F but less than 14 F. No adverse effects were reported. A digital data logger was involved. There was no product quality complaint involved. This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1702USA005004: US-009507513-1702USA005005:
Fever up to 104.2 starting 20NOV-23NOV tx w/APAP, high pitched scream 23NOV, not prolonged, but unusual, excessive sleeping-napped more than usual; MD requested DT in future;
I got a headache, a slight increase in temperature, and fatigue for the first two days.  These symptoms subsided, but I have had lingering muscle and joint pain. I got the J&J COVID-19 vaccine.
Nausea and vomiting followed by widespread muscle aches, severe and debilitating, has gone on for weeks requiring prednisone for symptom control.
In the clinic nurse found pneumococcal vaccine by Merck looks very much like the BOOSTRIX%D2 combined diphtheria-tetanus-aceullular pertussis (dTpa) vaccine by GlaxoSmithKline.  The top of each vial is the same color and both are stored in the medication fridge with potential for grabbing the wrong vial in the clinic.  We have photos of both vials, they look very much alike.  Error did not reach the patient.  No direct result of the error on the patient that we are aware of.
lethargy by 7pm, woke up with headache, chills, dizziness, nausea at 3:30am,  letting dog out into backyard, feeling like going to pass out, sat down, don't remember falling from chair but woke up on tile floor with lacerated scalp, skinned knees, severe joint and muscular pain along left shoulder, forearm, upper back, and left knee, unable to bear weight on leg, crawled from dinning room to bedroom and fell asleep on floor, woke the next morning with headache and nausea and muscle soreness, left knee with acute pain when flexing,
The day after the vaccination I started to be very itchy. I was also very tired and nauseous. Two days after the shot the itch was much worse. I did not have a visible rash, but I was very itchy. My legs were most itchy, but it was all over. I used Steroid ointment and it seemed to help. I was itchy for four weeks. After the first dose I had also been itchy for two weeks.
3/11/2021 vaccination Home BP, 3/14 was elevated 3/15 I called the midwives and they told me to come in for monitoring. I had got in range of gestation hypertension and that they should induce me.  I was induced on 3/15.  This was my second pregnancy, EDD was 3/16, birth weight was 6lbs 9oz.  *Post partem; high blood pressure. Magnesium treatment on 3/25
Possible allergic urticarial reaction just at site of injection. (Localized) redness/tenderness/warmth.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 09-NOV-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 0.5ml (lot # K012424, expiration date 05-JUN-2016). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time of the first time was 632 hours with the lowest recorded temperature of 34 Fahrenheit degree. The storage criteria and the type of excursion for this vaccine was refrigerator (R). No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Small red raised hives on face and diffuse red rash on upper chest noted on 10/4/16 - went to PCP.
started as lethargy, progressed to moderate/ marked body aches- full body joint based aching. also febrile, headache from  10pm until around 8am on 4/9.  Injection site pain until 4/11
Patient experienced near syncope after vaccination. Lasted less than 5 minutes. No cardiac symptoms. No  Resolved with orange juice as patient had not had PO intake for longer than 12 hours prior to vaccination.
Patient had episode of loss of consciousness and incontinence at time of injection.  Mother reported patient complained of headache and vomiting and received 10 fluids in ER approximately 12 hours after immunizations.  No further symptoms.
On his way out of the clinic stopped @ bathroom to vomit and developed rash on abd. Returned to peds with clinic RN supervisor. Was evaluated. BENADRYL susp given and immediately vomited. O2 started 4l/min and epipen given. Called 911 and was transported to hospital
Immediate wobbliness and loss of coordination, which stayed with me, getting some better over the next year, but still limits my daily life.  I took glutathione as recommended by my chiropracter, went to physical therapy, and am still doing PT.  Have an appointment with a neurologist the end of March.  Hopefully, will find out what was triggered by the booster, and what can be done, if anything.  I used a walker for the first three or four months, but barely left the house for fear of falling.  I did fall last August and broke a vertabrae in my back, then had a kyphoplasty to repair.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient. A 66-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Sep2022 at 12:00 as dose 5 (booster), single (Lot number: GH9703) at the age of 66 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "BPH" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "Known allergies: Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Naproxen, reaction(s): "Known allergies: naproxen". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Positive, notes: Covid reinfection. Other medication in 2weeks: Unknown. Anti-viral details: Product: Covid 19 Treatment, Brand: Paxlovid [Treatment start date: 08Oct2022, Treatment stop date: 12Oct2022, Indication: Treatment of Covid-19]. Therapeutic measures were taken as a result of drug ineffective, covid-19.  No follow-up attempts are possible. No further information is expected.
A day after receiving my third Gardasil injection, I got hives on my upper body, specifically my chest, neck, back, shoulders, arms, hands, and face. Dr. prescribed Atarax to relieve itching.
Severe body aches in shoulder, hips, torso, and legs; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 18Feb2021 at 00:30(at the age of 66-year-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 12Mar2021 at 00:00(at the age of 66-year-old) as a single dose for COVID-19 immunisation. Medical history included cancer, depression and allergy to statins. Concomitant medications included IC fluphenazine (MANUFACTURER UNKNOWN) 2.5 mg, ascorbic acid, calcium, mineral nos, retinol, tocopheryl acetate, vitamin nos, vitamin b nos, zinc(CENTRUM SILVER) and colecalciferol (VITAMIN D3) 50 mcg, all from unknown dates and for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Feb2021at 00:30, the patient experienced severe body aches in shoulder, hips, torso and legs which lasted eight weeks after first dose. The adverse event resulted in doctor or other healthcare professional office/clinic visit. The patient received IC Ibuprofen 800 mg three times a day as the treatment for the reported events. The clinical outcome of the event severe body aches was recovered on an unknown date in Apr2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
hands and arms have gone numb; got both shots in Aug and beginning at the end of Nov; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (005570). The reporter is the parent.  A 12 year-old female patient received bnt162b2 (BNT162B2), administration date Nov2021 (Batch/Lot number: unknown) as dose 2, single and administration date Aug2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (non-serious) with onset Nov2021, outcome "unknown", described as "got both shots in Aug and beginning at the end of Nov"; HYPOAESTHESIA (non-serious), outcome "not recovered", described as "hands and arms have gone numb". The event "hands and arms have gone numb" was evalated at the physician office visit.  Additional information: Reporter's 12 year daughter got both shots in August and beginning at the end of November her hands and arms have gone numb. Pediatrician and Neurologist can't figure out why. Reporter need to know if it was an adverse reaction to the vaccine and how to reverse it.  No follow-up attempts are possible, No further information is expected.
sideeffects were very painful; Pain around the injection site; joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013620A and 015M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Jan-2021, the patient experienced PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, PAIN (sideeffects were very painful), VACCINATION SITE PAIN (Pain around the injection site) and ARTHRALGIA (joint pain around the shoulder, pain in rotator cuff and/or joint of left arm/extreme pain in shoulder blade and rotator cuff) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications were not provided.  Patient has had an MRI and CT scan procedure, results are unknown.  Treatment information included prescription steroid pills discontinued.   This case was linked to MOD21-069007 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 05-Apr-2021: Contains significant information- Patient demographics and Vaccination date for first dose has been updated, event details and treatment information was added. On 28-Apr-2021: Contains significant information- Reporter address and event details has been added. New events for second dose and treatment information added. On 28-Apr-2021: Contains significant information -A new event was added.; Sender's Comments:  MOD21-069007:crosslinked